Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in IPO/Stock Watch

Cue Health Plans $180 Million US IPO for Home Healthcare Platform
Sino Biological Raises $772 Million in Shenzhen ChiNext IPO
I-Mab Plans Second Listing on Shanghai's STAR Board
Sirnaomics Plans $300 Million Hong Kong IPO for RNAi Portfolio
Mabworks Plans Hong Kong IPO to Support Antibody/Multi-Specifics Pipeline
ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China